| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO, Chairman Of The Board | Director, 10% Owner
2 companies
Legorreta Pablo G. is a Director, 10% Owner at PROKIDNEY CORP. with holdings across 2 companies. Recent SEC Form 4 filings include 9 buys and 0 sells.
Estimated insider holdings value: $96.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 13, 2024 | PROK Prokidney Corp. | Director, 10% Owner | Buy | 22,617,909 | $2.42 | $54,735,339.78 | New | -19.2% | -71.8% | |
| Jun 28, 2023 | RPRX Royalty Pharma Plc | CEO, Chairman Of The Board | Buy | 130,000 | $29.51 | $3,836,768.00 | +27.7% | -9.7% | -9.9% | |
| Jun 13, 2023 | RPRX Royalty Pharma Plc | CEO, Chairman Of The Board | Buy | 90,000 | $32.89 | $2,959,848.00 | +11.2% | -10.4% | -16.0% | |
| May 24, 2023 | RPRX Royalty Pharma Plc | CEO, Chairman Of The Board | Buy | 150,000 | $32.25 | $4,837,440.00 | +65.2% | -8.1% | -16.7% | |
| May 17, 2023 | RPRX Royalty Pharma Plc | CEO, Chairman Of The Board | Buy | 230,000 | $33.38 | $7,676,823.81 | +143.4% | -9.6% | -15.4% | |
| Jun 18, 2020 | RPRX Royalty Pharma Plc | CEO, Chairman Of The Board | Buy | 20,000 | $28.00 | $560,000.00 | New | - | - |